A disease-associated gene desert directs macrophage inflammation via ETS2
In-person only
Increasing rates of autoimmune and inflammatory disease present a burgeoning threat to human health. This is compounded by the limited efficacy of available treatments and high failure rates during drug development – highlighting an urgent need to better understand disease mechanisms. I will discuss our recent work that shows how functional genomics can address this challenge. By investigating an intergenic haplotype on chr21q22, independently linked to inflammatory bowel disease, ankylosing spondylitis, primary sclerosing cholangitis and Takayasu’s arteritis, we discover a central regulator of inflammatory responses in human macrophages and delineate a shared disease mechanism that can be targeted therapeutically.
Date:
10 June 2024, 12:00 (Monday, 8th week, Trinity 2024)
Venue:
Kennedy Institute of Rheumatology, Headington OX3 7FY
Venue Details:
Kennedy Lecture Theatre
Speaker:
Dr James Lee (The Francis Crick Institute)
Organising department:
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS)
Organiser:
Doris Chan (Kennedy Institute of Rheumatology)
Organiser contact email address:
doris.chan@kennedy.ox.ac.uk
Host:
Dr Franze Progatzky (University of Oxford - Kennedy Institute of Rheumatology)
Part of:
Kennedy Institute Seminars
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Doris Chan
